Plasma Biomarkers Ascertained With Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review

Plasma Biomarkers Ascertained With Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review

Introduction: Alzheimer's disease (AD) will become a prominent public health issue in the future given its cognitively debilitating nature. As the advent of global ageing society is expected, AD may bring tremendous socioeconomical costs if current diagnosis methods stay put. In this article, w...

Full description

Bibliographic Details
Main Authors: Pui-Un Tang, I-Hsieh Wu, Ian-Hou Lao, Wai Leong, Chaur-Jong Hu
Format: Article
Language:English
Published: Innovative Healthcare Institute 2021-01-01
Series:Innovations in Digital Health, Diagnostics, and Biomarkers
Subjects:
early-stage alzheimer's disease
immune-magnetic signal reduction
aβ40
aβ42
t-tau
tau protein
diagnosis
Online Access:https://theijpt.org/doi/pdf/10.36401/IDDB-20-04

Similar Items

Similar Items